Skip to main navigation Skip to search Skip to main content

Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

  • Wern Yew Ding
  • , Ameenathul Mazaya Fawzy
  • , Giulio Francesco Romiti
  • , Marco Proietti
  • , Daniele Pastori
  • , Menno V. Huisman
  • , Gregory Y.H. Lip*
  • , Dzifa Wosornu Abban
  • , Nasser Abdul
  • , Atilio Marcelo Abud
  • , Fran Adams
  • , Srinivas Addala
  • , Pedro Adragão
  • , Walter Ageno
  • , Rajesh Aggarwal
  • , Sergio Agosti
  • , Piergiuseppe Agostoni
  • , Francisco Aguilar
  • , Julio Aguilar Linares
  • , Luis Aguinaga
  • Jameel Ahmed, Allessandro Aiello, Paul Ainsworth, Jorge Roberto Aiub, Raed Al-Dallow, Lisa Alderson, Jorge Antonio Aldrete Velasco, Dimitrios Alexopoulos, Fernando Alfonso Manterola, Pareed Aliyar, David Alonso, Fernando Augusto Alves da Costa, José Amado, Walid Amara, Mathieu Amelot, Nima Amjadi, Fabrizio Ammirati, Marianna Andrade, Nabil Andrawis, Giorgio Annoni, Gerardo Ansalone, M. Kevin Ariani, Juan Carlos Arias, Sébastien Armero, Chander Arora, Muhammad Shakil Aslam, M. Asselman, Philippe Audouin, Gershan Davis, David Williams, the GLORIA-AF Investigators
*Corresponding author for this work
  • University of Liverpool
  • University of Rome La Sapienza
  • IRCCS Istituti Clinici Scientifici Maugeri
  • University of Milan
  • Leiden University
  • Aalborg University

Research output: Contribution to journalArticle (journal)peer-review

89 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases